Generation and Feasibility Assessment of a New Vehicle for Cell-Based Therapy for Treating Corneal Endothelial Dysfunction.
The corneal endothelium maintains corneal transparency by its pump and barrier functions; consequently, its decompensation due to any pathological reason causes severe vision loss due to corneal haziness. Corneal transplantation is the only therapeutic choice for treating corneal endothelial dysfunc...
Main Authors: | Naoki Okumura, Kazuya Kakutani, Ryota Inoue, Daiki Matsumoto, Tomoki Shimada, Makiko Nakahara, Yumiko Kiyanagi, Takehiro Itoh, Noriko Koizumi |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4927169?pdf=render |
Similar Items
-
Feasibility of cell-based therapy combined with descemetorhexis for treating Fuchs endothelial corneal dystrophy in rabbit model.
by: Naoki Okumura, et al.
Published: (2018-01-01) -
Application of Rho Kinase Inhibitors for the Treatment of Corneal Endothelial Diseases
by: Naoki Okumura, et al.
Published: (2017-01-01) -
Inhibition of TGF-β signaling enables human corneal endothelial cell expansion in vitro for use in regenerative medicine.
by: Naoki Okumura, et al.
Published: (2013-01-01) -
Feasibility of a cryopreservation of cultured human corneal endothelial cells.
by: Naoki Okumura, et al.
Published: (2019-01-01) -
Corneal endothelial expansion promoted by human bone marrow mesenchymal stem cell-derived conditioned medium.
by: Makiko Nakahara, et al.
Published: (2013-01-01)